TY - JOUR
T1 - Chronic heroin use disorder and the brain
T2 - current evidence and future implications
AU - Tolomeo, Serenella
AU - Steele, J. Douglas
AU - Ekhtiari, Hamed
AU - Baldacchino, Alex
N1 - Funding Information:
Dr. Tolomeo has received unrestricted educational grants from Indivior, Lundbeck and Merck Serono.
Funding Information:
Prof. Steele has received funding from the MRC, Wellcome Trust, Indivior and Wyeth. Dr. Ekhtiari had no conflicts of interest.
Funding Information:
Prof. Baldacchino has received funding from the MRC, CSO, and unrestricted educational grants from Schering-Plough, Merck Serono and Indivior. The authors declare no conflicts of interest with regard to this work.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2021/12/20
Y1 - 2021/12/20
N2 - The incidence of chronic heroin use disorder, including overdose deaths, has reached epidemic proportions. Here we summarise and evaluate our knowledge of the relationship between chronic heroin use disorder and the brain through a narrative review. A broad range of areas was considered including causal mechanisms, cognitive and neurological consequences of chronic heroin use and novel neuroscience-based clinical interventions. Chronic heroin use is associated with limited or very limited evidence of impairments in memory, cognitive impulsivity, non-planning impulsivity, compulsivity and decision-making. Additionally, there is some evidence for certain neurological disorders being caused by chronic heroin use, including toxic leukoencephalopathy and neurodegeneration. However, there is insufficient evidence on whether these impairments and disorders recover after abstinence. Whilst there is a high prevalence of comorbid psychiatric disorders, there is no clear evidence that chronic heroin use per se causes depression, bipolar disorder, PTSD and/or psychosis. Despite the growing burden on society from heroin use, knowledge of the long-term effects of chronic heroin use disorder on the brain remains limited. Nevertheless, there is evidence for progress in neuroscience-based interventions being made in two areas: assessment (cognitive assessment and neuroimaging) and interventions (cognitive training/remediation and neuromodulation). Longitudinal studies are needed to unravel addiction and neurotoxic mechanisms and clarify the role of pre-existing psychiatric symptoms and cognitive impairments.
AB - The incidence of chronic heroin use disorder, including overdose deaths, has reached epidemic proportions. Here we summarise and evaluate our knowledge of the relationship between chronic heroin use disorder and the brain through a narrative review. A broad range of areas was considered including causal mechanisms, cognitive and neurological consequences of chronic heroin use and novel neuroscience-based clinical interventions. Chronic heroin use is associated with limited or very limited evidence of impairments in memory, cognitive impulsivity, non-planning impulsivity, compulsivity and decision-making. Additionally, there is some evidence for certain neurological disorders being caused by chronic heroin use, including toxic leukoencephalopathy and neurodegeneration. However, there is insufficient evidence on whether these impairments and disorders recover after abstinence. Whilst there is a high prevalence of comorbid psychiatric disorders, there is no clear evidence that chronic heroin use per se causes depression, bipolar disorder, PTSD and/or psychosis. Despite the growing burden on society from heroin use, knowledge of the long-term effects of chronic heroin use disorder on the brain remains limited. Nevertheless, there is evidence for progress in neuroscience-based interventions being made in two areas: assessment (cognitive assessment and neuroimaging) and interventions (cognitive training/remediation and neuromodulation). Longitudinal studies are needed to unravel addiction and neurotoxic mechanisms and clarify the role of pre-existing psychiatric symptoms and cognitive impairments.
KW - Heroin
KW - Interventions
KW - Neurocognition
KW - Neuroimaging
KW - Neurology
KW - Neuroscience
KW - fMRI
KW - sMRI
UR - http://www.scopus.com/inward/record.url?scp=85095823086&partnerID=8YFLogxK
U2 - 10.1016/j.pnpbp.2020.110148
DO - 10.1016/j.pnpbp.2020.110148
M3 - Review article
C2 - 33169674
SN - 0278-5846
VL - 111
JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry
JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry
M1 - 110148
ER -